Regardless of the merits of the shorter's arguments, MSB at $2 billion + is priced for some degree of success.
If there are hiccups (as there are with most biotechs), the consequences are going to be very spectacular.
Disclaimer: have watched MSB with great envy from the sidelines.
Regardless of the merits of the shorter's arguments, MSB at $2...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 69437 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |